Divis Laboratories share price falls more than 4% in early trade, partially recovers

Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Shares of Divis Laboratories declined by as much as 4.2% to an intraday low of Rs 6,545.00 in early trade, before partially recovering losses. At 10.15 am, the stock was trading down 2% at Rs 6,702, reflecting a negative sentiment in the market. Divis Laboratories is included as one of the stocks in the NIFTY NEXT 50 index.

Divis Laboratories' financial performance shows consistent growth in revenue and net profit. Here's an overview of the company's consolidated financial data:

The quarterly financial performance of Divis Laboratories indicates a steady increase in both revenue and net profit across the quarters.

The revenue for the quarter-ending March 2025 stood at Rs 2,585.00 Crore, up from Rs 2,303.00 Crore in March 2024. The net profit for the same period increased from Rs 538.00 Crore to Rs 662.00 Crore. Earnings per share (EPS) also rose from 20.25 to 24.93.

The yearly financial performance demonstrates consistent growth in revenue and net profit.

The revenue for the year-ending March 2025 increased to Rs 9,360.00 Crore from Rs 7,845.00 Crore in March 2024. The net profit also rose to Rs 2,191.00 Crore from Rs 1,600.00 Crore. The Earnings per share (EPS) increased from Rs 60.27 to Rs 82.53.

The income statement provides a detailed breakdown of Divis Laboratories' financial performance over the past five years.

Sales increased from Rs 7,845 Crore in March 2024 to Rs 9,360 Crore in March 2025. Total expenditure also saw an increase from Rs 6,018 Crore to Rs 6,794 Crore. The net profit increased from Rs 1,600 Crore in March 2024 to Rs 2,191 Crore in March 2025.

Sales increased from Rs 2,303 Crore in March 2024 to Rs 2,585 Crore in March 2025. Total expenditure also saw an increase from Rs 1,667 Crore to Rs 1,806 Crore. The net profit increased from Rs 538 Crore in March 2024 to Rs 662 Crore in March 2025.

Cash flow provides an overview of the company's sources and uses of cash.

The balance sheet provides a snapshot of the company's assets, liabilities, and equity.

The financial ratios provide insights into the company's performance and financial health.

Divis Laboratories has announced several corporate actions, including dividend payouts and bonus issues.

• Dividends: The company has consistently paid dividends. A final dividend of Rs.30.00 per share (1500%) was announced on May 19, 2025, with an effective date of July 25, 2025.
• Bonus Issues: Divis Laboratories has issued bonus shares in the past, with bonus ratios of 1:1 announced on August 8, 2015, and June 6, 2009.

Divis Laboratories announced newspaper publication regarding the 35th AGM and record date for dividend and other information on July 11, 2025. The company communicated information to shareholders regarding deduction of income tax at source from payment of dividend for the financial year 2024-25 on May 29, 2025.

Divis Laboratories' stock movement reflects the early market sentiment.